CL2015000803A1 - Compuestos derivados de acido hialuronico modificados; y su uso como suplemento cosmético en la reparacion de defectos o lesion de tejido, aumento de mama hipoplastica, prevencion o tratamiento de la celulitis o arrugas, trastornos de las articulaciones osteoartritis, sinovitis, entre otros - Google Patents

Compuestos derivados de acido hialuronico modificados; y su uso como suplemento cosmético en la reparacion de defectos o lesion de tejido, aumento de mama hipoplastica, prevencion o tratamiento de la celulitis o arrugas, trastornos de las articulaciones osteoartritis, sinovitis, entre otros

Info

Publication number
CL2015000803A1
CL2015000803A1 CL2015000803A CL2015000803A CL2015000803A1 CL 2015000803 A1 CL2015000803 A1 CL 2015000803A1 CL 2015000803 A CL2015000803 A CL 2015000803A CL 2015000803 A CL2015000803 A CL 2015000803A CL 2015000803 A1 CL2015000803 A1 CL 2015000803A1
Authority
CL
Chile
Prior art keywords
cellulite
synovitis
wrinkles
lesions
repair
Prior art date
Application number
CL2015000803A
Other languages
English (en)
Spanish (es)
Inventor
Pietro Antonino Di
Francesca Cavazza
Paolo Caliceti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000803(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of CL2015000803A1 publication Critical patent/CL2015000803A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
CL2015000803A 2012-10-09 2015-03-31 Compuestos derivados de acido hialuronico modificados; y su uso como suplemento cosmético en la reparacion de defectos o lesion de tejido, aumento de mama hipoplastica, prevencion o tratamiento de la celulitis o arrugas, trastornos de las articulaciones osteoartritis, sinovitis, entre otros CL2015000803A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187828 2012-10-09

Publications (1)

Publication Number Publication Date
CL2015000803A1 true CL2015000803A1 (es) 2015-08-07

Family

ID=47022522

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000803A CL2015000803A1 (es) 2012-10-09 2015-03-31 Compuestos derivados de acido hialuronico modificados; y su uso como suplemento cosmético en la reparacion de defectos o lesion de tejido, aumento de mama hipoplastica, prevencion o tratamiento de la celulitis o arrugas, trastornos de las articulaciones osteoartritis, sinovitis, entre otros

Country Status (21)

Country Link
US (1) US20150252120A1 (enExample)
EP (1) EP2906193B1 (enExample)
JP (1) JP2015533190A (enExample)
KR (1) KR20150065861A (enExample)
CN (1) CN104703583A (enExample)
AR (1) AR092922A1 (enExample)
AU (1) AU2013328842A1 (enExample)
BR (1) BR112015007823A2 (enExample)
CA (1) CA2886144A1 (enExample)
CL (1) CL2015000803A1 (enExample)
EA (1) EA201590708A1 (enExample)
HK (1) HK1210941A1 (enExample)
IL (1) IL238103A0 (enExample)
IN (1) IN2015DN02358A (enExample)
MX (1) MX2015004386A (enExample)
PE (1) PE20150713A1 (enExample)
PH (1) PH12015500585A1 (enExample)
SG (1) SG11201501992XA (enExample)
TW (1) TW201414478A (enExample)
WO (1) WO2014056841A1 (enExample)
ZA (1) ZA201503171B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途
DE202014008682U1 (de) * 2014-07-11 2015-08-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
EP3397241A1 (en) * 2015-12-30 2018-11-07 Asafov, Alexander Vilenovich Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses
RU2625766C1 (ru) * 2016-07-19 2017-07-18 Александр Ливиевич Ураков Средство для экстренного восстановления голоса при внезапной афонии
CN116891540A (zh) * 2018-03-22 2023-10-17 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
EP3793525A4 (en) * 2018-05-16 2022-02-16 Emory University PALLADIUM HYALURONIC ACID PARTICLES AND METHODS OF MANAGEMENT OF CANCER OR ANGIOGENIC DISEASES
CN119176959B (zh) * 2024-09-18 2025-07-04 云南贝泰妮生物科技集团股份有限公司 一种透明质酸-聚乳酸共聚物交联凝胶及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8713662D0 (en) 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1251151B (it) 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
CA2445985A1 (en) 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
ITMI20021666A1 (it) 2002-07-26 2004-01-26 Jasper Ltd Liability Co Derivati dell'acido ialuronico
US20110027357A1 (en) * 2004-02-18 2011-02-03 Isaac Gilinski Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en) 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
CA2593064A1 (en) 2004-12-30 2006-07-06 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
CN101677912B (zh) 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
EP2162158A2 (en) 2007-05-23 2010-03-17 Allergan, Inc. Coated hyaluronic acid particles
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing

Also Published As

Publication number Publication date
EP2906193B1 (en) 2016-09-28
TW201414478A (zh) 2014-04-16
CA2886144A1 (en) 2014-04-17
KR20150065861A (ko) 2015-06-15
BR112015007823A2 (pt) 2017-07-04
JP2015533190A (ja) 2015-11-19
US20150252120A1 (en) 2015-09-10
HK1210941A1 (en) 2016-05-13
ZA201503171B (en) 2016-11-30
AU2013328842A1 (en) 2015-04-09
PE20150713A1 (es) 2015-05-16
PH12015500585A1 (en) 2015-05-04
IN2015DN02358A (enExample) 2015-09-04
SG11201501992XA (en) 2015-04-29
EP2906193A1 (en) 2015-08-19
WO2014056841A1 (en) 2014-04-17
AR092922A1 (es) 2015-05-06
IL238103A0 (en) 2015-05-31
CN104703583A (zh) 2015-06-10
MX2015004386A (es) 2015-06-10
EA201590708A1 (ru) 2015-07-30

Similar Documents

Publication Publication Date Title
HUS2500031I1 (hu) Humánellenanyag-farmakon konjugátum szöveti faktor ellen
GB2552758B (en) Improvements in or relating to assemblies for use in knee replacement surgery
EP2844161A4 (en) BONE COLLECTION
PL2928484T3 (pl) Związki przydatne w leczeniu lub pielęgnacji skóry, włosów lub błon śluzowych oraz ich kompozycji kosmetycznych lub farmaceutycznych
BRPI1013409A2 (pt) células de tecido de cordão umbilical humano como terapia para doença de alzheimer
ES2533145R1 (es) Procedimiento cosmético para reducir el tejido adiposo subcutáneo
IL237649B (en) Polymer meters drug for use in the prevention, diagnosis and/or treatment of diseases of the joint
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
EP2956049A4 (en) SYSTEM FOR NON-INVASIVE DETERMINATION OF THE PRESENCE OF WATER IN A TISSUE
HRP20190318T1 (hr) Farmaceutski ili kozmetički pripravak za liječenje alopecije
PL2614838T3 (pl) Dikwafozol i kwas hialuronowy lub ich sole do zastosowania w leczeniu zespołu suchego oka
EA201592073A1 (ru) Фармацевтические композиции, содержащие коллаген и гиалуронат натрия
PL3226854T3 (pl) Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
PL2911754T3 (pl) Medyczny zestaw do podparcia nogi przystosowany do zwiększenia zakresu ruchu nogi w celu wspomagania gojenia i wzmocnienia uszkodzonej, zranionej i/lub wymienionej kości, mięśnia i/lub tkanki nogi
ZA201902275B (en) Topical dressing composition for the treatment of damaged skin tissue
BR112015007861A2 (pt) prótese de tecido
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
IL236823A0 (en) Preparations for use in the treatment of bone defects
EP2785356A4 (en) USE OF THE PULLULAN TO REDUCE THE APPEARANCE OF SCARES OR TISSUE
BR112014028878A2 (pt) composição cosmética, método de tratamento cosmético da pele e uso de uma composição cosmética
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
PL2983691T3 (pl) Synergistyczna kombinacja alanino-glutaminy, kwasu hialuronowego i wyciągu z owsa i jej zastosowanie w kompozycji przeznaczonej do zabliźniania ran i naprawiania uszkodzeń skóry
EP2934380A4 (en) FIBRO-INTEGRATED HYDROGELS FOR TISSUE TISSUE TREATMENT
EP2882376A4 (en) Total knee replacement substituting function of anterior cruciate ligament